A 62-year-old man with a 40 pack-year smoking history presents with hemoptysis. CT chest shows a 3 cm peripheral lung nodule with irregular margins. Which imaging feature best distinguishes primary lung cancer from a benign nodule?

Explanation

## Distinguishing Malignant from Benign Lung Nodules **Key Point:** Spiculated or irregular margins with pleural tethering are the most specific imaging features of malignancy. These reflect tumor-induced desmoplastic reaction and invasion of adjacent pleura. ### Comparative Imaging Features | Feature | Malignant Nodule | Benign Nodule | |---------|-----------------|---------------| | **Margins** | Spiculated, irregular, ill-defined | Smooth, well-circumscribed | | **Pleural tethering** | Present (invasion) | Absent | | **Size** | Variable (>2 cm more suspicious) | Usually <2 cm | | **Calcification** | Eccentric or absent | Central, diffuse, popcorn (benign patterns) | | **Growth rate** | Doubling time 20–400 days | Stable over 2+ years | **High-Yield:** The **Fleischner Society criteria** emphasize that margin morphology (spiculation, irregularity) is more specific for malignancy than size alone. A 1 cm spiculated nodule is more suspicious than a 3 cm smooth nodule. **Clinical Pearl:** Pleural tethering (retraction of pleura toward the nodule) indicates visceral pleural invasion, a hallmark of lung cancer. This finding is virtually absent in benign lesions. **Mnemonic:** **SPAM** — **S**piculated, **P**leural tethering, **A**ttached to pleura = **M**alignant. ### Why Margin Morphology is the Best Discriminator 1. **Size alone is unreliable** — benign nodules can exceed 2 cm; small malignancies exist 2. **Absence of calcification is non-specific** — many benign nodules also lack calcification 3. **Peripheral location is common to both** — not discriminatory 4. **Spiculation and pleural tethering are highly specific** — reflect tumor biology (desmoplasia, invasion) ```mermaid flowchart TD A[Lung nodule detected]:::outcome --> B{Margin morphology?}:::decision B -->|Smooth, well-defined| C[Likely benign]:::outcome B -->|Spiculated, irregular| D[Pleural tethering?]:::decision D -->|Yes| E[Highly suspicious for malignancy]:::urgent D -->|No| F[Intermediate suspicion]:::outcome F --> G[Follow-up CT or PET-CT]:::action ``` [cite:Fleischner Society Guidelines 2017; Harrison 21e Ch 85]